Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1999
11/04/1999WO1999042477A8 Transporter protein for saccharide-coupled medicaments
11/04/1999WO1999042090A3 Treating cancer
11/04/1999WO1999041984A9 INTERACTION BETWEEN THE MEC1-DEPENDENT DNA SYNTHESIS CHECKPOINT AND G1 CYCLIN FUNCTION IN $i(SACCAROMYCES CEREVISIAE)
11/04/1999WO1999040205A8 Glycosyltransferase and dna encoding the same
11/04/1999WO1999039006A3 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
11/04/1999WO1999037788A9 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/04/1999WO1999037775A3 Compositions and methods for detecting and treating breast cancer
11/04/1999WO1999036545A3 Adenoviral vectors with modified capsid proteins
11/04/1999WO1999036536A9 Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system
11/04/1999WO1999034819A3 Use of citrulline peptides derived from filaggrin for treating autoimmune diseases
11/04/1999WO1999034004A3 Metastatic breast and colon cancer regulated genes
11/04/1999WO1999034002A3 Proteases from gram positive organisms
11/04/1999WO1999033981A3 Human signal peptide-containing proteins
11/04/1999WO1999031256A3 Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis
11/04/1999WO1999029865A9 A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof
11/04/1999WO1999024589A3 Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof
11/04/1999WO1999019481A3 Mammalian genes involved in viral infection and tumor suppression
11/04/1999WO1998045425A9 DEVELOPMENT OF HIGH-ETHANOL RESISTANT $i(ESCHERICHIA COLI)
11/04/1999WO1997049812A3 Process for extracting and purifying recombinant, non-lipidised osp-protein
11/04/1999DE19840964C1 Novel nucleic acid, used to inhibit production of glutamine for facilitation of sugar recovery from the juice
11/04/1999DE19820190A1 Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor Human nucleic acid sequences from pancreatic tumor
11/04/1999DE19819735A1 Vorrichtung und Verfahren zur Herstellung einer Anordnung von Kettenmolekülen auf einem Trägermaterial Apparatus and method for manufacturing an array of chain molecules on a support material
11/04/1999CA2330574A1 Nucleoside triphosphates and their incorporation into ribozymes
11/04/1999CA2330560A1 Methods for transducing fusion molecules
11/04/1999CA2330277A1 Reduced complexity nucleic acid targets and methods of using same
11/04/1999CA2330033A1 Method of treating endotoxemia
11/04/1999CA2329975A1 Process for obtaining stem cells
11/04/1999CA2329908A1 Targeted gene delivery to cells by filamentous bacteriophage
11/04/1999CA2328992A1 Nr-cam gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors
11/04/1999CA2328598A1 Microbial preparation of substances from aromatic metabolism/iii
11/04/1999CA2327506A1 Combination viral-based and gene-based therapy of tumors
11/04/1999CA2327505A1 Monoclonal antibodies with reduced immunogenicity
11/04/1999CA2327504A1 Cd40-interacting and traf-interacting proteins
11/04/1999CA2327456A1 Nucleic acids of the m antigen gene of histoplasma capsulatum, antigens, vaccines and antibodies, methods and kits for detecting histoplasmosis
11/04/1999CA2327444A1 Construction of retroviral producer cells from adenoviral and retroviral vectors
11/04/1999CA2327381A1 Human proteins having transmembrane domains and dnas encoding these proteins
11/04/1999CA2327352A1 Novel serine protease capable of selective cleavage of insulin-like growth factor binding protein
11/04/1999CA2327317A1 Polynucleotides isolated from skin cells and methods for their use
11/04/1999CA2327178A1 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto
11/04/1999CA2327176A1 Methods for modulating differentiation
11/04/1999CA2326825A1 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth
11/04/1999CA2326824A1 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
11/04/1999CA2326820A1 Polypeptides from moraxella (branhamella) catarrhalis
11/04/1999CA2326819A1 Delivery of therapeutic proteins via implantation of genetically modified cells in the omentum
11/04/1999CA2326757A1 Regulation of biofilm formation
11/04/1999CA2326755A1 G-csf receptor agonist antibodies and screening method therefor
11/04/1999CA2326697A1 Primer extension methods for detecting nucleic acids
11/04/1999CA2326695A1 Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis c virus infection
11/04/1999CA2326627A1 Nucleotide sequences for detecting enterohemorrhagic escherichia coli (ehec)
11/04/1999CA2326601A1 Ese genes and proteins
11/04/1999CA2326500A1 Process for preparing doxorubicin
11/04/1999CA2326496A1 Cloning and expressing the aspergillus oryzae bgii .beta.-glucosidase gene
11/04/1999CA2326404A1 Basb013 dna and proteins from neisseria meningitidis
11/04/1999CA2326380A1 Recombinant secoisolariciresinol dehydrogenase, and methods of use
11/04/1999CA2326377A1 Internalizing erbb2 antibodies
11/04/1999CA2326376A1 Polyepitope carrier protein
11/04/1999CA2326375A1 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
11/04/1999CA2326233A1 Delayed rectifier potassium channel subunit
11/04/1999CA2326001A1 Fizz proteins
11/04/1999CA2325869A1 A novel g-protein coupled receptor
11/04/1999CA2325823A1 Gene screening methods and related assays
11/04/1999CA2325463A1 A method for increasing the protein content of plants
11/04/1999CA2325055A1 Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis
11/04/1999CA2323759A1 Novel nucleic acids and polypeptides related to a farnesyl-directed cysteine carboxymethyltransferase
11/04/1999CA2323235A1 Adenoviral vectors for treating disease
11/04/1999CA2295105A1 Generation of packaging system for human recombinant adenoviral vectors
11/04/1999CA2269846A1 Techniques for synthesis integrity evaluation utilizing cycle fidelity probes
11/03/1999EP0953649A1 Nitrogen-substituted silicone useful for compacting nucleic acids and use thereof for transfecting cells
11/03/1999EP0953648A2 Viral defective vaccine produced by transcomplementing cell line
11/03/1999EP0953647A1 Method for preparing retrovirus vector for gene therapy
11/03/1999EP0953646A2 Herbicide tolerant transgenic plants where the herbicide inhibits prophyrin biosynthesis
11/03/1999EP0953645A2 Transcription factor controlling phenylpropanoid biosynthesis pathway
11/03/1999EP0953644A1 Systems for the mass production of proteins or peptides by microorganisms of the genus humicola
11/03/1999EP0953643A2 Raffinose synthase genes and their use
11/03/1999EP0953642A1 Antigenic protein originating in infectious laryngotracheitis virus
11/03/1999EP0953641A2 Polynucleotide molecules encoding neospora proteins
11/03/1999EP0953640A2 cDNA sequences of genes involved in the induction of resistance in plants
11/03/1999EP0953639A1 FAPalpha-specific antibody with improved producibility
11/03/1999EP0953638A1 Human vanilloid receptor-like cation channel
11/03/1999EP0953637A2 Acetylcholine receptor
11/03/1999EP0953636A2 Cytokine signal regulators
11/03/1999EP0953635A1 Improved methods for extracting nucleic acids from tissue samples and paraffin-embedded tissues
11/03/1999EP0953576A1 Active hedgehog protein conjugate, process for its production and use
11/03/1999EP0953572A2 Peptides binding to bone marrow stromal cell antigen
11/03/1999EP0953056A1 Nucleic acid sequencing with solid phase capturable terminators
11/03/1999EP0953054A1 Ehv-1 vectors
11/03/1999EP0953053A2 Viral particles which are masked or unmasked with respect to a cell receptor
11/03/1999EP0953052A1 Crossless retroviral vectors
11/03/1999EP0953051A1 Use of chemokine antagonist molecules for their antiviral activity, particularly against an hiv type retrovirus
11/03/1999EP0953050A1 Novel means for the diagnosis, prevention and treatment of contamination or infections by viruses with mucous tropism
11/03/1999EP0953049A2 Novel human metallothionein
11/03/1999EP0953048A1 Compounds for modulating cell negative regulations and biological applications thereof
11/03/1999EP0953047A2 VACCINE CONTAINING A PEROXIREDOXIN AND/OR A beta-TUBULIN
11/03/1999EP0953046A1 Human hematopoietic stem and progenitor cell antigen and methods for its use
11/03/1999EP0953045A1 Method of recovering a biological molecule from a recombinant microorganism
11/03/1999EP0953044A2 Gene for adenylate cyclase and its use
11/03/1999EP0953043A1 Genes and gene products related to werner's syndrome
11/03/1999EP0953042A1 Methods and reagents for regulating telomere length and telomerase activity
11/03/1999EP0953041A1 Serum-free mammalian cell culture medium, and uses thereof
11/03/1999EP0953039A1 Animal models of human prostate cancer progression
1 ... 3332 3333 3334 3335 3336 3337 3338 3339 3340 3341 3342 3343 3344 3345 3346 3347 3348 3349 3350 3351 3352 ... 4023